Endo Pharmaceuticals
Pharmaceutical Company
Based in DC
AI Overview
With $30K in lobbying spend across 1 quarterly filings, Endo Pharmaceuticals is an active lobbying client. Their lobbying covers 2 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Endo Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues
Taxation/Internal Revenue Code
Issues relating to incentives for life sciences research.
Treatment of inbound companies in comprehensive tax reform; Treasury regulations relating to Section 385.
Issues relating to prescription drug abuse.
Issues relating to incentives for tamper-resistant formulations.
Issues relating to FDA approvals of new drugs and generic drugs.
Issues related to the FDA
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.